2025年全球藥品市場：發展現狀與關鍵數據透視

報告大廳

2025/07/16

中國報告大廳網訊，在國際貿易政策持續調整的大背景下，藥品行業的格局正經歷深刻變化。隨着多國政府對供應鏈安全和產業競爭力的關注日益增強，關稅措施成為影響全球醫藥市場的關鍵變量。最新數據顯示，2025年上半年美國市場進口藥品規模按年上升12%，但政策不確定性正在重塑行業生態。一、藥品市場面臨重大貿易政策挑戰：發展現狀及藥品統計數據中國報告大廳發布的《2025-2030年中國藥品市場專題研究及...

網頁鏈接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2551811826"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2551811826\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2551811826?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-07-16 08:20","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2551811826","market":"us","top_or_hot":-1,"title":"2025年全球藥品市場：發展現狀與關鍵數據透視","media":"報告大廳","content":"<div>\n<p>中國報告大廳網訊，在國際貿易政策持續調整的大背景下，藥品行業的格局正經歷深刻變化。隨着多國政府對供應鏈安全和產業競爭力的關注日益增強，關稅措施成為影響全球醫藥市場的關鍵變量。最新數據顯示，2025年上半年美國市場進口藥品規模按年上升12%，但政策不確定性正在重塑行業生態。  一、藥品市場面臨重大貿易政策挑戰：發展現狀及藥品統計數據  中國報告大廳發布的《2025-2030年中國藥品市場專題研究及...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071608393095441ff0&s=b\">網頁鏈接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2025年全球藥品市場：發展現狀與關鍵數據透視</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2025年全球藥品市場：發展現狀與關鍵數據透視\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">報告大廳</strong><span class=\"h-time small\">2025-07-16 08:20</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>中國報告大廳網訊，在國際貿易政策持續調整的大背景下，藥品行業的格局正經歷深刻變化。隨着多國政府對供應鏈安全和產業競爭力的關注日益增強，關稅措施成為影響全球醫藥市場的關鍵變量。最新數據顯示，2025年上半年美國市場進口藥品規模按年上升12%，但政策不確定性正在重塑行業生態。  一、藥品市場面臨重大貿易政策挑戰：發展現狀及藥品統計數據  中國報告大廳發布的《2025-2030年中國藥品市場專題研究及...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071608393095441ff0&s=b\">網頁鏈接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071608393095441ff0&s=b\">報告大廳</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2237443978.SGD","symbol_name":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071608393095441ff0&s=b","article_id":"2551811826","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071608393095441ff0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2551811826","pubTimestamp":1752625215,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"最新數據顯示，2025年上半年美國市場進口藥品規模按年上升12%，但政策不確定性正在重塑行業生態。數據顯示，當前全球藥品貿易總額中，發展中國家佔比已從2020年的28%升至34%，政策工具的選擇將深刻影響這一趨勢走向。2025年藥品市場呈現顯著的政策驅動特徵。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","SG9999014906.USD":"大华全球优质成长基金Acc USD","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU2552382215.SGD":"WELLINGTON US BRAND POWER \"A\" (SGDHDG) ACC","BK4534":"瑞士信贷持仓","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","LU0094547139.USD":"abrdn SICAV I - GLOBAL SUSTAINABLE EQUITY FUND \"A\" (USD) ACC","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","IE00BK4W5L77.USD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (USD) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0109391861.USD":"富兰克林美国机遇基金A Acc","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","LU1127390331.HKD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"A\" (HKD) ACC","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","LU0471298777.SGD":"Blackrock Nutrition A2 SGD-H","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","LU1712237335.SGD":"Natixis Mirova Global Sustainable Equity H-R-NPF/A SGD","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","LU2361045086.USD":"WELLINGTON US QUALITY GROWTH \"A\" (USD) ACC","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","LU0234572021.USD":"高盛美国核心股票组合Acc","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU2746668461.USD":"MANULIFE DYNAMIC LEADERS \"AA\" (USD) ACC","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU2750360997.AUD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (AUDHDG) INC","LU0058720904.USD":"联博国际健康护理基金A","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU0079474960.USD":"联博美国增长基金A","SG9999018865.SGD":"United Global Quality Growth Fd Cl Dist SGD-H","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LLY":"礼来","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","SG9999017495.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"B\" (SGD) ACC","LU1814569148.SGD":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","BK4581":"高盛持仓","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","IE00BJLML261.HKD":"HSBC GLOBAL EQUITY INDEX \"HCH\" (HKD) ACC"},"translate_title":"Global Pharmaceutical Market 2025: Development Status and Key Data Perspectives","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":0.9},"content_text":"中國報告大廳網訊，在國際貿易政策持續調整的大背景下，藥品行業的格局正經歷深刻變化。隨着多國政府對供應鏈安全和產業競爭力的關注日益增強，關税措施成為影響全球醫藥市場的關鍵變量。最新數據顯示，2025年上半年美國市場進口藥品規模按年上升12%，但政策不確定性正在重塑行業生態。  一、藥品市場面臨重大貿易政策挑戰：發展現狀及藥品統計數據  中國報告大廳發布的《2025-2030年中國藥品市場專題研究及市場前景預測評估報告》指出，近期消息顯示，美國政府可能最早在本月末對進口藥品啓動低關税試點，並計劃於一年後將税率提升至最高200%。這一舉措與半導體產業的類似關税方案同步推進，預計將直接影響禮來、默克等依賴海外生產的製藥企業。據行業統計，約45%的美國市場藥品供應來自跨境生產網絡，政策變動或將導致藥企成本增加，並間接推高消費者支出。  二、半導體關聯產業受波及：藥品供應鏈與國際貿易動態  除直接針對藥品外，對半導體徵收關税的計劃也引發連鎖反應。芯片作為製藥設備的核心組件之一，其進口税率調整可能影響藥品生產效率和成本結構。美國政府同時提出對銅產品徵收50%關税，並已與印尼達成19%的雙向關税協議，涉及150億美元能源採購及45億美元農產品交易。此類政策組合進一步凸顯全球供應鏈重構趨勢。  三、國際合作與關税博弈：藥品貿易協議背後的經濟邏輯  儘管面臨爭議，美國正通過多邊談判爭取更多貿易讓步。據透露，已有至少五國進入深度磋商階段，包括潛在達成協議可能性較高的印度市場。對於未參與單獨議價的國家，美國可能實施統一税率（約10%以上）。數據顯示，當前全球藥品貿易總額中，發展中國家佔比已從2020年的28%升至34%，政策工具的選擇將深刻影響這一趨勢走向。  2025年藥品市場呈現顯著的政策驅動特徵。關税調整不僅重塑企業戰略佈局，更通過成本傳導機制影響終端消費者。在半導體、銅資源等上游產業聯動下，藥品供應鏈的安全性與經濟性面臨雙重考驗。數據顯示，若最高税率全面落地，全球製藥行業年度貿易額可能減少約15%-20%，而新興市場國家的議價能力將成為未來博弈焦點。當前國際貿易規則重構背景下，藥品行業的全球化進程正進入關鍵轉折點。更多藥品行業研究分析，詳見中國報告大廳《藥品行業報告匯總》。這裏匯聚海量專業資料，深度剖析各行業發展態勢與趨勢，為您的決策提供堅實依據。更多詳細的行業數據盡在【數據庫】，涵蓋了宏觀數據、產量數據、進出口數據、價格數據及上市公司財務數據等各類型數據內容。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}